Close

Ratings by Piper Sandler (Edward A. Tenthoff)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
8/5/2022 Opko Health OPK Maintain Overweight
(N/A)
 
 
  Details
6/22/2022 Moderna MRNA Maintain Overweight
(N/A)
 
 
  Details
6/22/2022 CRISPR Therapeutics CRSP Maintain Overweight
(N/A)
 
 
  Details
6/2/2022 Aeglea Biotherapeutics AGLE Downgrade Neutral
(Overweight)
1.50
(0.53)
-64.67% Details
5/23/2022 Seres Therapeutics MCRB Maintain Overweight
(N/A)
 
 
  Details
5/23/2022 Fate Therapeutics FATE Maintain Overweight
(N/A)
 
 
  Details
5/23/2022 Eloxx Pharma ELOX Maintain Overweight
(N/A)
 
 
  Details
5/23/2022 Bicycle Therapeutics BCYC Maintain Overweight
(N/A)
 
 
  Details
5/23/2022 Aslan Pharma ASLN Maintain Overweight
(N/A)
 
 
  Details
5/23/2022 Arvinas Inc. ARVN Maintain Overweight
(N/A)
 
 
  Details
5/23/2022 Aeglea Biotherapeutics AGLE Maintain Overweight
(N/A)
 
 
  Details
5/18/2022 Moderna MRNA Maintain Overweight
(N/A)
 
 
  Details
5/11/2022 Arrowhead Pharma ARWR Maintain Overweight
(N/A)
 
 
  Details
5/10/2022 Opko Health OPK Maintain Overweight
(N/A)
 
 
  Details
5/9/2022 Aeglea Biotherapeutics AGLE Maintain Overweight
(N/A)
 
 
  Details
1/18/2022 Opko Health OPK Maintain Overweight
(N/A)
 
 
  Details
12/6/2021 Aeglea Biotherapeutics AGLE Maintain Overweight
(N/A)
 
 
  Details
11/15/2021 Yumanity Therapeutics Inc. YMTX Maintain Overweight
(N/A)
 
 
  Details
11/4/2021 Moderna MRNA Maintain Overweight
(N/A)
 
 
  Details
10/8/2021 Bicycle Therapeutics BCYC Maintain
(N/A)
 
 
  Details
9/20/2021 Synlogic Inc. SYBX Maintain Overweight
(N/A)
 
 
  Details
8/9/2021 Cytokinetics CYTK Maintain Overweight
(N/A)
 
 
  Details
7/30/2021 Opko Health OPK Maintain Overweight
(N/A)
 
 
  Details
7/22/2021 Seres Therapeutics MCRB Maintain Overweight
(N/A)
 
 
  Details
7/22/2021 Arvinas Inc. ARVN Maintain Overweight
(N/A)
 
 
  Details
7/19/2021 Cytokinetics CYTK Maintain Overweight
(N/A)
 
 
  Details
7/13/2021 Bicycle Therapeutics BCYC Maintain Overweight
(N/A)
 
 
  Details
6/21/2021 Arrowhead Pharma ARWR Maintain Overweight
(N/A)
 
 
  Details
5/26/2021 Moderna MRNA Maintain Overweight
(N/A)
 
 
  Details
5/19/2021 Eloxx Pharma ELOX Maintain Overweight
(N/A)
 
 
  Details
5/11/2021 Aslan Pharma ASLN Maintain Overweight
(N/A)
 
 
  Details
5/7/2021 Moderna MRNA Maintain Overweight
(N/A)
 
 
  Details
5/6/2021 Fate Therapeutics FATE Maintain Overweight
(N/A)
 
 
  Details
4/15/2021 Moderna MRNA Maintain Overweight
(N/A)
 
 
  Details
3/4/2021 Fulcrum Therapeutics FULC Maintain Overweight
(N/A)
 
 
  Details
2/17/2021 Fate Therapeutics FATE Maintain Overweight
(N/A)
 
 
  Details
11/6/2020 Fate Therapeutics FATE Maintain Overweight
(N/A)
 
 
  Details
10/21/2020 CRISPR Therapeutics CRSP Maintain Overweight
(N/A)
 
 
  Details
10/14/2020 Proteostasis Therapeutics PTI Upgrade Overweight
(Neutral)
1.19
(1.11)
-6.72% Details
9/21/2020 Exelixis EXEL Maintain Overweight
(N/A)
 
 
  Details
8/14/2020 Aptevo Therapeutics APVO Maintain Overweight
(N/A)
 
 
  Details
7/31/2020 Opko Health OPK Maintain Overweight
(N/A)
 
 
  Details
7/23/2020 Cytokinetics CYTK Maintain Overweight
(N/A)
 
 
  Details
7/14/2020 Cytokinetics CYTK Maintain Overweight
(N/A)
 
 
  Details
7/8/2020 Opko Health OPK Maintain Overweight
(N/A)
 
 
  Details
6/26/2020 Aptevo Therapeutics APVO Maintain Overweight
(N/A)
 
 
  Details
5/14/2020 Aptevo Therapeutics APVO Maintain Overweight
(N/A)
 
 
  Details
5/12/2020 Marker Therapeutics MRKR Downgrade Neutral
(Overweight)
2.40
(0.36)
-85% Details
2/28/2020 Aptevo Therapeutics APVO Maintain Overweight
(N/A)
 
 
  Details
2/27/2020 Exelixis EXEL Maintain Overweight
(N/A)
 
 
  Details
2/11/2020 Marker Therapeutics MRKR Maintain Overweight
(N/A)
 
 
  Details
6/25/2019 Eloxx Pharma ELOX Maintain Overweight
(Overweight)
 
 
  Details